1-9 of 9
Bingcao Wu
Close
Sort by
Journal Articles

Real-World Treatment Outcomes of Teclistamab Under an Outpatient Model for Step-up Dosing Administration

Tyler B. Sandahl, Scott A. Soefje, Ediz S. Calay, Yi Lin, Rafael Fonseca, Sikander Ailawadhi, Ricardo Parrondo, Dee Lin, Bingcao Wu, Eli Silvert, Nina Kim, Corinne Carpenter, Tyler E. Wagner, Jessica Fowler, Laura Hester, Alexander Marshall, Patrick Stoy, Dina Gifkins, Shaji Kunnathu Kumar
Journal: Blood
Blood (2023) 142 (Supplement 1): 5154.
https://doi.org/10.1182/blood-2023-174270
Published: 2023
Journal Articles

Real-World Patient Profile and Step-up Dosing Process of Early Initiators of Teclistamab for Multiple Myeloma in US Hospitals - an Updated Analysis Using Premier Healthcare Database

Carlyn Rose Tan, Nina Kim, Eric Chinaeke, Laura Hester, Jessica Fowler, Dina Gifkins, Dee Lin, Sian Walker, Alex Z. Fu, Bingcao Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3792.
https://doi.org/10.1182/blood-2023-178896
Published: 2023
Journal Articles

Panel Interview of Oncology Practices with Emergent Experience of Teclistamab in the Real World: The Tec-Pioneer Study

Ben A Derman, Meaghan Roach, Dee Lin, Bingcao Wu, Richard Murphy, Nina Kim, Margaret Doyle, Nadya Prood, Jessica Fowler, Alexander Marshall, Amal Jamaleddine, Agne Paner-Straseviciute
Journal: Blood
Blood (2023) 142 (Supplement 1): 7249.
https://doi.org/10.1182/blood-2023-187479
Published: 2023
Journal Articles

Evolving Real-World Characteristics and Step-up Dosing Among Early Initiators of Teclistamab for Multiple Myeloma - a National All-Payer Claims Database Study

Rahul Banerjee, Nina Kim, Monal Kohli, Laura Hester, Emily Achter, Jessica Fowler, Emeka Umeh, Dee Lin, Gideon Aweh, Dina Gifkins, Sian Walker, Bingcao Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 5087.
https://doi.org/10.1182/blood-2023-178908
Published: 2023
Journal Articles

Burden of Hospitalization before and after a Disease Progression Following Triple-Class Exposure in Patients with Relapsed and Refractory Multiple Myeloma

Jennifer S Harper, Alex Z. Fu, Dee Lin, Bingcao Wu, Nina Kim, Savanna Ledford, Sundar Jagannath
Journal: Blood
Blood (2022) 140 (Supplement 1): 5214–5215.
https://doi.org/10.1182/blood-2022-167617
Published: 2022
Journal Articles

Patients' and Caregivers' Perspectives from Social Media Towards Disease Burden and Innovative Treatment Options in Multiple Myeloma

Dee Lin, Jordan Richardson, Nina Kim, Savanna Ledford, Josh Feldman, Paul Boyce, Bingcao Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 5244–5245.
https://doi.org/10.1182/blood-2022-167813
Published: 2022
Journal Articles

A US National View of Prevalent and Newly Diagnosed Multiple Myeloma in 2021: A Retrospective Analysis of National All-Payer Claims Database

Dee Lin, Yihang Liu, Nina Kim, Savanna Ledford, Aerin Sun, Kimberly Brunisholz, Rohan Medhekar, Lisa Abramovitz, Keshia Maughn, Victor Johnson, Michael Schultz, Bingcao Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 932–933.
https://doi.org/10.1182/blood-2022-167474
Published: 2022
Journal Articles

Economic Burden of Emergency Room (ER) Visits and Hospitalizations Among Newly Diagnosed Multiple Myeloma (NDMM) Patients in the United States

Eric M Maiese, PhD, Xinmei Zhu, PhD, Bingcao Wu, Yen-Wen Chen, Sikander Ailawadhi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4715.
https://doi.org/10.1182/blood-2019-127071
Published: 2019
Journal Articles

Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Treatment Among Morbidly Obese Patients with Venous Thromboembolism

Alex C. Spyropoulos, MD, Veronica Ashton, MPH, Yen-Wen Chen, Bingcao Wu, Eric D. Peterson
Journal: Blood
Blood (2018) 132 (Supplement 1): 2537.
https://doi.org/10.1182/blood-2018-99-115144
Published: 2018